Confronto

Buserelin vs. Epitalon

Due peptidi a confronto — identità, base di evidenze, stato legale ed eventi avversi noti.

Identità

Categoria

Ricerca (altro)

N. CAS

57982-77-1

307297-39-8

Peso molecolare

1239.42 g/mol

390.35 g/mol

Emivita

nessun dato

0.3 h

Sequenza

nessun dato

Ala-Glu-Asp-Gly

Meccanismo d'azione

Buserelin

Buserelin is a potent GnRH agonist: after an initial stimulatory surge ('flare'), continuous receptor occupancy causes downregulation and thereby suppression of LH, FSH and the downstream sex hormones.

Epitalon

Postulated mechanisms include modulation of gene expression in pinealocytes, telomerase activation (observed in cell culture studies) and influence on melatonin synthesis. A defined primary receptor is not established; the mechanistic basis rests on in-vitro and animal data from the Khavinson group.

Base di evidenze

Evidenza più alta

RCT sull'uomo

Studio sull'uomo

Studi

di cui sull'uomo

Effetti registrati

Contraddizioni aperte

Eventi avversi documentati

Stato legale

Country	Buserelin	Epitalon
Germania	Su prescrizione	Non approvato
RU	—	Solo ricerca
Stati Uniti	Non approvato	Non approvato

Voci complete

Frequently asked questions

What is the difference between Buserelin and Epitalon?: Buserelin is classified as "Ricerca (altro)", while Epitalon is classified as "Ricerca (altro)". Buserelin: Buserelin is a synthetic GnRH agonist (including as a nasal spray). It is used in endometriosis, hormone-dependent prostate cancer and assisted reproduction; approved in Europe (Suprefact), not in the US. Epitalon: Synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from the pineal extract epithalamin (V. Khavinson, St. Petersburg). Investigated in the Russian research and anti-ageing context; Western controlled trials are largely absent. No medicines approval in EU or US. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Buserelin or Epitalon?: The highest available evidence level is "RCT sull'uomo" for Buserelin and "Studio sull'uomo" for Epitalon. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Buserelin and Epitalon in Germany and the United States?: Germania: Buserelin — Su prescrizione, Epitalon — Non approvato. Stati Uniti: Buserelin — Non approvato, Epitalon — Non approvato. These are factual summaries with source and review date on the individual pages.

Country

Buserelin

Epitalon

Germania

Su prescrizione

Non approvato

—

Solo ricerca

Stati Uniti

Non approvato

Frequently asked questions

What is the difference between Buserelin and Epitalon?

Buserelin is classified as "Ricerca (altro)", while Epitalon is classified as "Ricerca (altro)". Buserelin: Buserelin is a synthetic GnRH agonist (including as a nasal spray). It is used in endometriosis, hormone-dependent prostate cancer and assisted reproduction; approved in Europe (Suprefact), not in the US. Epitalon: Synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from the pineal extract epithalamin (V. Khavinson, St. Petersburg). Investigated in the Russian research and anti-ageing context; Western controlled trials are largely absent. No medicines approval in EU or US. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Buserelin or Epitalon?

The highest available evidence level is "RCT sull'uomo" for Buserelin and "Studio sull'uomo" for Epitalon. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Buserelin and Epitalon in Germany and the United States?

Germania: Buserelin — Su prescrizione, Epitalon — Non approvato. Stati Uniti: Buserelin — Non approvato, Epitalon — Non approvato. These are factual summaries with source and review date on the individual pages.